http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36425460

Outgoing Links

Predicate Object
contentType Journal Article|Review
issn 2079-9721
issueIdentifier 4
pageRange 177-
publicationName Diseases (Basel, Switzerland)
startingPage 177
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4aef8b7bfee0cabbcdbd895008db735b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_31594eeabfdf646375ade8171786372b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2bd80ca58c0ca01b07d3d9de4b3f104b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_92a8c7860b9170e4a626b2eb0c55b6a1
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a500274ddff6e3ece320321eaa155c72
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cf88f9236626e243775df7994cc945ed
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2564035c971d56f16324e1cf7d88fdea
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_426de379839a00eb21cf3b4f63406d3c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_36b8bba3e5bca5b3ff5cc1c47f0eb6bc
bibliographicCitation Chowdhury N, Kundu A. Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus. Diseases. 2023 Dec 10;11(4). PMID: 38131983; PMCID: PMC10742622.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d877b12c4a74d35b66fb0fcf6eb2e218
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3956-1003
date 2023-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC10742622
https://pubmed.ncbi.nlm.nih.gov/38131983
https://doi.org/10.3390/diseases11040177
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42828
https://portal.issn.org/resource/ISSN/2079-9721
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus

Total number of triples: 30.